- Home
- ELWS vs ADTX Comparison
ELWS vs ADTX Comparison
Compare ELWS & ADTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELWS
- ADTX
- Stock Information
- Founded
- ELWS 2018
- ADTX 2017
- Country
- ELWS Japan
- ADTX United States
- Employees
- ELWS N/A
- ADTX N/A
- Industry
- ELWS
- ADTX Biotechnology: Pharmaceutical Preparations
- Sector
- ELWS
- ADTX Health Care
- Exchange
- ELWS Nasdaq
- ADTX Nasdaq
- Market Cap
- ELWS 5.9M
- ADTX 5.3M
- IPO Year
- ELWS 2023
- ADTX 2020
- Fundamental
- Price
- ELWS $1.91
- ADTX $2.30
- Analyst Decision
- ELWS
- ADTX
- Analyst Count
- ELWS 0
- ADTX 0
- Target Price
- ELWS N/A
- ADTX N/A
- AVG Volume (30 Days)
- ELWS 30.9K
- ADTX 589.6K
- Earning Date
- ELWS 06-03-2025
- ADTX 05-19-2025
- Dividend Yield
- ELWS N/A
- ADTX N/A
- EPS Growth
- ELWS N/A
- ADTX N/A
- EPS
- ELWS N/A
- ADTX N/A
- Revenue
- ELWS $2,292,406.00
- ADTX $133,985.00
- Revenue This Year
- ELWS N/A
- ADTX $15,768.94
- Revenue Next Year
- ELWS N/A
- ADTX N/A
- P/E Ratio
- ELWS N/A
- ADTX N/A
- Revenue Growth
- ELWS 404.13
- ADTX N/A
- 52 Week Low
- ELWS $1.04
- ADTX $2.04
- 52 Week High
- ELWS $8.68
- ADTX $27,200.00
- Technical
- Relative Strength Index (RSI)
- ELWS 43.84
- ADTX 30.46
- Support Level
- ELWS $1.91
- ADTX $2.21
- Resistance Level
- ELWS $2.20
- ADTX $2.39
- Average True Range (ATR)
- ELWS 0.34
- ADTX 0.39
- MACD
- ELWS 0.00
- ADTX 0.49
- Stochastic Oscillator
- ELWS 30.99
- ADTX 11.11
About ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.